📣We are thrilled to welcome Isavella Georgiades to CN Bio ! Isavella joins us as a Research Assistant in the Toxicology R&D team, bringing a fresh perspective and a passion for scientific discovery. She recently graduated with an MRes in Regenerative Medicine and Stem Cells Biology and holds a BSc in Biochemistry from Newcastle University, where she honed her scientific skills through various research projects. During her Master's research project, Isavella investigated the effects of a telomerase-targeting drug on immortalised cardiomyocytes, a project which sparked her interest in in vitro toxicity and how drugs impact human cell lines. She is excited to be at the forefront of innovative Organ-on-a-chip technology at CN Bio, with the opportunity to contribute to scientific advancements in drug discovery. Beyond the lab, Isavella enjoys exploring the world through films 🎬and cooking🥘. She loves movies that delve into existentialism, with one of her favourites being "2001: A Space Odyssey." Even in her leisure she doesn't leave her meticulous ways behind, often gravitating towards complex and detailed recipes - from prawn wontons to Basque cheesecake, she has tried many recipes from across the world. 👏Please join us and give Isavella Georgiades a warm welcome to CN Bio. 👉If you're interested in joining our team? We're hiring! Check out our current job vacancies: https://lnkd.in/dHMZfMJE #NewHire #OrganOnAChipCompany #CareersinBiotech
CN Bio
Biotechnology Research
Cambridge, England 6,424 followers
Generate human-specific efficacy and safety data with PhysioMimix® Single- and Multi-organ microphysiological systems.
About us
CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of their human counterparts in vitro. The approach provides a viable alternative to animal models where translatability to humans is predicted to be poor and for testing advanced drug modalities where human-specific targets and pathways are required. They generate physiologically relevant, human-translatable, mechanistic data that enables researchers to progress only the safest and most efficacious drugs into in vivo animal studies and be better prepared for clinical trials. Please follow us for regular updates. It starts here.
- Website
-
http://www.cn-bio.com
External link for CN Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, England
- Type
- Privately Held
- Founded
- 2008
- Specialties
- Organ-on-a-chip, Hepatitis B, drug discovery, liver disease, containment level 3 laboratory, microfluidic cell culture, precision biology, non-alcoholic steatohepatitis, Organ-on-Chip, Preclinical drug discovery, Microphysiological systems, Safety Toxicology, non-alcoholic fatty liver disorder, Contract Research Services, PhysioMimix OOC, Drug-induced liver injury, ADME, disease modeling, 3D cell culture, Aminal alternative, New Alternative approaches, COVID 19, Drug absorption, Drug metabolism, Bioavailability, Respiratory infection, and DILI
Locations
-
Primary
332 Cambridge Science Park
Milton Road
Cambridge, England CB4 0WN, GB
Employees at CN Bio
-
Sarah Payne
Marketing Manager at CN Bio Innovations
-
Hugh Dyson IEng FIMechE
Head Of Production at CN Bio Innovations (Leader of an excellent, empowered team covering: manufacturing, service, purchasing and logistics)
-
Andrew Murray
Lead Software Engineer at CN Bio
-
Joe Parisi
Director of Sales, Americas
Updates
-
We are excited to announce that CN Bio has been shortlisted for a Business Weekly newspaper Award! While the specific category remains a secret until the ceremony, this recognition is a huge testament to our team's dedication to innovation in the organ-on-a-chip (OOC) field. CN Bio's PhysioMimix® OOC range of microphysiological systems (MPS) is modernizing the drug development process by providing human-specific in vitro data early in the drug development pipeline to better inform in vivo experimental design and clinical trial programs. This not only accelerates drug discovery but also improves the success rate of clinical trials, ultimately leading to the faster development of life-saving therapies. We're incredibly honored to be shortlisted alongside other innovative companies. Stay tuned for more updates as the awards ceremony approaches! #BusinessWeeklyAwards #OrganOnAChipCompany If you want to learn more about CN Bio's OOC technology? Check out our website https://hubs.ly/Q02GVLjn0
-
We are excited to announce our second speaker for the CN Bio User Group Meeting 2024 - Dr. Claire Caygill, a Post-Doctoral Research Associate in Infection Biology and Therapeutics at Liverpool School of Tropical Medicine, working with our PhysioMimix® lung-on-a-chip to characterize SARS-CoV-2 variants in the upper and lower airways, as well as our liver-on-a-chip to assess the potential of therapeutic candidates. Don't miss this chance to hear from a long-term PhysioMimix user about their experiences with CN Bio. Register today to secure your spot. 👉 https://hubs.ly/Q02GRp8_0 Stay tuned to find out more about Dr. Caygill's talk, and other speaker announcements - coming soon! #CNBioAt #UGM24 #CustomerExperience #EventSpeaker
-
📣1 hour to go! Our #LearningLab & #Live Q&A in partnership with Genetic Engineering & Biotechnology News, with Dr. Tomasz Kostrzewski and Dr. Clive Roper BSc PhD CBiol CSci ERT FRSB is starting soon. Register and attend the #webinar to learn about the rapidly evolving world of Organ-on-a-Chip (OOC) technology. Join the discussion on: - The transformative power of OOC - The rising costs and complexities of new drug modalities - Reducing animal use whilst maintaining scientific rigor -The evolving regulatory landscape for OOC acceptance 👉 Sign up here: https://hubs.ly/Q02GxLKt0 #CNBioAt #NAM
-
Find out how Organ-on-a-chip providers, regulatory agencies, and drug developers are working together to modernize the drug development process. The end goal is to bring safer medicines to market faster, more cost effectively, and thorugh the use of fewer animals. 👉 Read the blog: https://lnkd.in/gCWkcnc6 👉 Join the discussion and register for our upcoming Learning Lab in partnership with Genetic Engineering & Biotechnology News (GEN) on 15 July, 14:00 (London): https://hubs.ly/Q02FgthG0 #CNBioAt #LearningLab #OrganOnAChip #NAM
-
"Before I came here, I didn't have much of an idea about what Organ-on-a-chip meant" - Mirella Smutek, Cambridge Academy for Science & Technology. Dr. Dharaminder Singh and our amazing STEM team recently hosted Mirella, a placement student, for a few days. They dove deep into the fascinating world of microphysiological systems (MPS), exploring the potential and benefits of Organ-on-a-chip (#OOC) technology. Mirella also witnessed the diverse range of scientific expertise that drives innovation at CN Bio . Curious about her experience? Watch Mirella's short interview where she shares how her experience with us completely changed her understanding of OOC and its future! 👉If you’re thinking of a career in the exciting field of OOC, check out our open vacancies - we're looking for bright minds like you to join our team! https://hubs.ly/Q02FVQbD0 #STEM #OrganOnAChipCompany #InspiringTheNextGen #CNBioLife
-
Join our CSO, Dr. Tomasz Kostrzewski and toxicology consultant dr. Clive Roper BSc PhD CBiol CSci ERT FRSB for a CN Bio #LearningLab in partnership with Genetic Engineering & Biotechnology News (GEN). This session is ideal for you, if you: 1. attended our May Learning Lab and have follow-up questions 2. missed the previous broadcast and want to learn more about the potential and regulatory implications of #OOC Don't miss this chance to: - Learn from experienced industry professionals - Gain valuable insights on OOC's future - Participate in a live Q&A session 👉 Register Now! https://hubs.ly/Q02FgthG0 #CNBioAt #OrganOnAChip #LiveLearningLab #LIVEQ&A #Webinar
I'll be returning for another CN Bio Learning Lab alongside Clive Roper BSc PhD CBiol CSci ERT FRSB on the 15th of July in partnership with Genetic Engineering & Biotechnology News. Join us for the discussion on: - The transformative power of Organ-on-a-chip (OOC) in drug discovery - Addressing the rising costs and complexities of new drug modalities - Reducing animal use whilst maintaining scientific rigor -The evolving regulatory landscape for OOC acceptance The session will be ideal if you have questions on OOC adoption and missed the previous broadcast and want to learn more about the potential and regulatory implications of OOC! Sign up here: https://hubs.ly/Q02FgthG0 #CNBioAt #OrganOnAChip #LiveLearningLab
-
📢We're delighted to introduce Aubrey Wharton III - our new Americas East Sales Manager! Aubrey joins CN Bio with a wealth of sales experience, most recently from IDT Corporation and is very excited to be back at a fast-growing establishment, and we can't wait to see his energy drive success in the Americas East region. Aubrey's competitive spirit extends beyond the sales floor – he's renowned for maintaining the finest lawn in the neighborhood, without the help of any fancy landscaping services, of course! When he’s is not closing deals, he enjoys globetrotting with his wife, Rita, and their three children, exploring new cultures, from the Caribbean islands to the majestic Lake Tahoe and beyond!🌅 Join us in extending a hearty CN Bio welcome to Aubrey! 👉If you would like to be part of the CN Bio team, check out our current job vacancies at https://hubs.ly/Q02FyC-K0 #NewHire #AmericasEast #OrganOnAChipCompany
-
We're excited to present this thought-provoking Live Learning Lab - Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption in partnership with Genetic Engineering & Biotechnology News (GEN). Join our Chief Scientific Officer, Dr. Tomasz Kostrzewski and renowned toxicology consultant, Dr. Clive Roper BSc PhD CBiol CSci ERT FRSB as they delve into the rapidly evolving world of Organ-on-a-Chip (OOC) technology. 📅 15th July 2024, Monday 🕓 06:00 PST | 09:00 EST | 14:00 BST | 15:00 CET 📍 Online 👉 Register now to secure your spot! https://hubs.ly/Q02FgthG0 This insightful session will explore how OOC: • Is transforming drug discovery with its predictive and cost-effective approach • Tackles rising costs and prepares for the complexities of new drug modalities • Helps reduce and refine animal use while maintaining scientific rigor • Addresses current industry challenges and what OOC providers are doing to overcome them • Is changing the regulatory landscape - acceptance status, including the regulator’s viewpoint and ongoing efforts to support increased use #CNBioAt #OrganOnAChip #LiveLearningLab #GEN